Glypin®
Glimepiride
Antidiabetic
4mg
Glimepiride is a sulphonylurea that acts mainly by directly stimulating the release of insulin from functioning beta cells of pancreatic islet tissue. To achieve this, it inhibits the ATP potassium channels on the beta cell membrane and potassium efflux
Info Sheet
Glypin® Met
Glimepiride and Metformin Hydrochloride
Antidiabetic
2/500mg
Glypin® MET combines two antihyperglycaemic agents with complimentary mechanisms of action to improve glycemic control in patients with type 2 diabetes: Glimepiride, a member of the Sulfonylurea class, and Metformin hydrochloride, a member of the Biguanide class.
Info Sheet